SCHEMBL29948124

SCHEMBL29948124

COC(=O)c1cc(C#N)ccc1-c1nc2c(OC)c(C(N)=O)ccc2n1CCn1c(-c2ccc(C#N)cc2C(=O)OC)nc2c(OC)c(C(N)=O)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.40
PKN2 Q16513 1/20 0.40
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
PTGER4 P35408 4/20 0.36
AR P10275 1/20 0.35
PARP1 P09874 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM4E B2RXH2 3/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
IDH1 O75874 2/20 0.34
MEN1 O00255 1/20 0.34
ALOX5AP P20292 3/20 0.34
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23529392 1.00 PKN1 (0.40) PKN1PKN2JAK2JAK1TYK2
SCHEMBL23552685 0.93 PKN1 (0.35) PKN1PKN2JAK2JAK1TYK2
SCHEMBL29948231 0.91 PTGER4 (0.39) PKN1PKN2JAK2JAK1TYK2
SCHEMBL23529382 0.91 PTGER4 (0.39) PKN1PKN2JAK2JAK1TYK2
SCHEMBL23530087 0.86 ABL1 (0.41) PKN1PKN2PTGER4ALDH1A1TDP1
SCHEMBL29948168 0.85 PTGER4 (0.47) PKN1PKN2JAK2JAK1TYK2
SCHEMBL23552505 0.85 PTGER4 (0.47) PKN1PKN2JAK2JAK1TYK2
SCHEMBL29948181 0.83 PKN1 (0.47) PKN1PKN2PTGER4PARP1IDH1
SCHEMBL23552540 0.83 PKN1 (0.47) PKN1PKN2PTGER4PARP1IDH1
SCHEMBL25095233 0.81 ABL1 (0.43) PKN1PKN2JAK2PTGER4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077318-B1 BENZIMIDAZOLE DIMERS AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-10-15 EP claimed
CN-114981265-B Compounds of formula (I) CTXT私人有限公司 2025-01-03 CN claimed
EP-4077318-A1 COMPOUNDS CTXT PTY LTD (AU) 2022-10-26 EP claimed
CN-114981265-A Compound (I) CTXT私人有限公司 2022-08-30 CN claimed
US-20260132112-A1 COMPOUNDS CTXT PTY LTD (AU) 2026-05-14 US disclosed
US-12415785-B2 Compound modulators of sting CTXT PTY LTD (AU) 2025-09-16 US disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415785-B2 Compound modulators of sting STING1, IRF3, MAVS PKN1 2995/4885PKN2 3870/4885JAK2 2484/4885
US-20260132112-A1 COMPOUNDS STING1, IRF3, CGAS PKN1 3602/4885PKN2 3792/4885JAK2 2576/4885
US-20230062932-A1 COMPOUNDS STING1, IRF3, MAVS PKN1 2987/4885PKN2 3800/4885JAK2 2083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.